But some say the data doesn't reflect layoffs underway and that job opportunities are tightening in the white-collar sector ... and his girlfriend, Julie Wilson (ph), in Washington state, there ...

Emmy-winning composer Cristóbal Tapia de Veer says he won't return for season four after warring with the show's creator: "We had our last fight forever." By James Hibberd Writer-at-Large You ...

Cristóbal Tapia de Veer didn’t tell show creator Mike White until the very last minute, “for the shock” after repeated “fights” with creator Mike White. Entertainment Reporter The White ...

Cristóbal Tapia de Veer is cutting his stay at “The White Lotus” short. The composer behind the HBO dramedy’s widely praised score has quit ahead of the show’s fourth season, telling The ...

(Source: Getty Images) De Veer claims that White “wasn’t happy” with his original compositions for the show, and that it was a “struggle” to get White to give his “weird” sound a chance.

We may earn commission on some of the items you choose to buy. Romantic TV shows have earned their place as the coziest, most cathartic kind of binge. Whether it’s a period drama filled with ...

Co-written by Laura Dern and The White Lotus creator and writer Mike White, both of who also star in the show, Enlightened centers on Amy Jellicoe (Dern), a corporate executive who has a public ...

Who died? Did Gaitok shoot? What happened to the lorazepam? As Mike White's HBO anthology wraps up its third season, we're ...

the guy who makes the White Lotus themes just did an interview with the NYT announcing that he's leaving the show because of how Mike White wanted the music and released the "uncut" version of the ...

Elsewhere in the interview, White touched on another complaint the show has been receiving, explaining how people expect it to follow a specific formula. "People now come into the show thinking it ...

"The White Lotus" composer Cristobal Tapia de Veer is leaving the HBO anthology series after experiencing creative disagreements with the show's team ... played on a TV. “My disappointment ...

Findings confirmed the approved 600mg IV dose was optimal for slowing disability progression in relapsing MS. A phase 3 study evaluating a higher dose of ocrelizumab in adults with relapsing ...